Omarigliptin alleviates cognitive dysfunction in Streptozotocin-induced diabetic mouse

References

• Guthrie RA, Guthrie DW. Pathophysiology of diabetes mellitus. Crit Care Nurs Q. 2004;27(2):113–125.
   PubMedGoogle Scholar
• Cole JB, Florez JC. Genetics of diabetes mellitus and diabetes complications. Nat Rev Nephrol. 2020;16(7):377–390.
   PubMed Web of Science ®Google Scholar
• Petersmann A, Müller-Wieland D, Müller UA, et al. Definition, classification and diagnosis of diabetes mellitus. Exp Clin Endocrinol Diabetes. 2019;127(S 01):S1–S7.
   PubMedGoogle Scholar
• Zimmet P, Alberti KG, Magliano DJ, Bennett PH, et al. Diabetes mellitus statistics on prevalence and mortality: facts and fallacies. Nat Rev Endocrinol. 2016;12(10):616–622.
   PubMed Web of Science ®Google Scholar
• Srikanth V, Sinclair AJ, Hill-Briggs F, et al. Type 2 diabetes and cognitive dysfunction-towards effective management of both comorbidities. Lancet Diabetes Endocrinol. 2020;8(6):535–545.
   PubMed Web of Science ®Google Scholar
• Yerrapragada DB, Rao CR, Karunakaran K, et al. Cognitive dysfunction among adults with Type 2 diabetes mellitus in Karnataka, India. Ochsner J. 2019;19(3):227–234.
   PubMed Web of Science ®Google Scholar
• Biessels GJ, Despa F. Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications. Nat Rev Endocrinol. 2018;14(10):591–604.
   PubMed Web of Science ®Google Scholar
• Dos Santos JM, Tewari S, Mendes RH. The role of oxidative stress in the development of diabetes mellitus and its complications. J Diabetes Res. 2019;2019:4189813.
   PubMed Web of Science ®Google Scholar
• Evans PM, Bain SC. Omarigliptin for the treatment of type 2 diabetes mellitus. Expert Opin Pharmacother. 2016;17(14):1947–1952.
   PubMed Web of Science ®Google Scholar
• Hattori S. Omarigliptin decreases inflammation and insulin resistance in a pleiotropic manner in patients with type 2 diabetes. Diabetol Metab Syndr. 2020;12:24.
   PubMed Web of Science ®Google Scholar
• Li L, Qian K, Sun Y, et al. Omarigliptin ameliorated high glucose-induced nucleotide oligomerization domain-like receptor protein 3 (NLRP3) inflammasome activation through activating adenosine monophosphate-activated protein kinase alpha (AMPKalpha) in renal glomerular endothelial cells. Bioengineered. 2021;12(1):4805–4815.
   PubMed Web of Science ®Google Scholar
• Hattori S, Nomoto K, Suzuki T, et al. Beneficial effect of omarigliptin on diabetic patients with non-alcoholic fatty liver disease/non-alcoholic steatohepatitis. Diabetol Metab Syndr. 2021;13(1):28.
   PubMed Web of Science ®Google Scholar
• Ohara M, Nagaike H, Fujikawa T, et al. Effects of omarigliptin on glucose variability and oxidative stress in type 2 diabetes patients: a prospective study. Diabetes Res Clin Pract. 2021;179:108999.
   PubMed Web of Science ®Google Scholar
• Ayoub BM, Mowaka S, Safar MM, et al. Repositioning of Omarigliptin as a once-weekly intranasal anti-parkinsonian agent. Sci Rep. 2018;8(1):8959.
   PubMedGoogle Scholar
• Du H, Wang S. Omarigliptin mitigates lipopolysaccharide-induced neuroinflammation and dysfunction of the integrity of the blood-brain barrier. ACS Chem Neurosci. 2020;11(24):4262–4269.
   PubMed Web of Science ®Google Scholar
• Marcus JM, Andrabi SA. SIRT3 regulation under cellular stress: making sense of the ups and downs. Front Neurosci. 2018 Nov 2;12:799.
   PubMed Web of Science ®Google Scholar
• Jacobs KM, Pennington JD, Bisht KS, et al. SIRT3 interacts with the daf-16 homolog FOXO3a in the mitochondria, as well as increases FOXO3a dependent gene expression. Int J Biol Sci. 2008 Sep 5;4(5):291–299.
   PubMed Web of Science ®Google Scholar
• Yu Y, Hu LL, Liu L, et al. Hsp22 ameliorates lipopolysaccharide-induced myocardial injury by inhibiting inflammation, oxidative stress, and apoptosis. Bioengineered. 2021;12(2):12544–12554.
   PubMed Web of Science ®Google Scholar
• Kim YH, Kim YS, Kang SS, et al. Resveratrol inhibits neuronal apoptosis and elevated Ca2+/calmodulin-dependent protein kinase II activity in diabetic mouse retina. Diabetes. 2010;59(7):1825–1835.
   PubMed Web of Science ®Google Scholar
• Jiang LY, Tang -S-S, Wang X-Y, et al. PPARgamma agonist pioglitazone reverses memory impairment and biochemical changes in a mouse model of type 2 diabetes mellitus. CNS Neurosci Ther. 2012;18(8):659–666.
   PubMed Web of Science ®Google Scholar
• Du J, Yin G, Hu Y, et al. Coicis semen protects against focal cerebral ischemia-reperfusion injury by inhibiting oxidative stress and promoting angiogenesis via the TGFbeta/ALK1/Smad1/5 signaling pathway. Aging (Albany NY). 2020;13(1):877–893.
   PubMedGoogle Scholar
• Chen WX, Wang HQ, Liu J, et al. Interference of KLF9 relieved the development of gestational diabetes mellitus by upregulating DDAH2. Bioengineered. 2022;13(1):395–406.
   PubMed Web of Science ®Google Scholar
• Biessels GJ, Staekenborg S, Brunner E, et al. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol. 2006;5(1):64–74.
   PubMed Web of Science ®Google Scholar
• Kaludercic N, Di Lisa F. Mitochondrial ROS formation in the pathogenesis of diabetic cardiomyopathy. Front Cardiovasc Med. 2020;7:12.
   PubMed Web of Science ®Google Scholar
• Ni R, Zheng D, Xiong S, et al. Mitochondrial Calpain-1 disrupts ATP synthase and induces superoxide generation in Type 1 diabetic hearts: a novel mechanism contributing to diabetic cardiomyopathy. Diabetes. 2016;65(1):255–268.
   PubMed Web of Science ®Google Scholar
• Cadenas S. Mitochondrial uncoupling, ROS generation and cardioprotection. Biochim Biophys Acta Bioenerg. 2018;1859(9):940–950.
   PubMed Web of Science ®Google Scholar
• Satoh A, Imai SI, Guarente L. The brain, sirtuins, and ageing. Nat Rev Neurosci. 2017;18(6):362–374.
   PubMed Web of Science ®Google Scholar
• Singh CK, Singh CK, Chhabra G, Ndiaye MA, Garcia-Peterson LM, Mack NJ, Ahmad N, et al. The role of Sirtuins in antioxidant and redox signaling. Antioxid Redox Signal. 2018;28(8):643–661.
   PubMed Web of Science ®Google Scholar
• Tseng AH, Shieh SS, Wang DL. SIRT3 deacetylates FOXO3 to protect mitochondria against oxidative damage. Free Radic Biol Med. 2013;63:222–234.
   PubMed Web of Science ®Google Scholar
• Liu Y, Ao X, Ding W, et al. Critical role of FOXO3a in carcinogenesis. Mol Cancer. 2018;17(1):104.
   PubMedGoogle Scholar
• Nho RS, Hergert P. FoxO3a and disease progression. World J Biol Chem. 2014;5(3):346–354.
   PubMedGoogle Scholar
• Sosnowska B, Mazidi M, Penson P, et al. The sirtuin family members SIRT1, SIRT3 and SIRT6: their role in vascular biology and atherogenesis. Atherosclerosis. 2017;265:275–282.
   PubMed Web of Science ®Google Scholar
• Madamanchi NR, Vendrov A, Runge MS. Oxidative stress and vascular disease. Arterioscler Thromb Vasc Biol. 2005;25(1):29–38.
   PubMed Web of Science ®Google Scholar
• Chen YH, Zhang JY, Lin Y, Lei QY, Guan KL, Zhao DM, Xiong Y, et al. Tumour suppressor SIRT3 deacetylates and activates manganese superoxide dismutase to scavenge ROS. EMBO Rep. 2011;12(6):534–541.
   PubMed Web of Science ®Google Scholar